Immunologic features of HIV-1-infected women on HAART at delivery
✍ Scribed by Erika Ono; Amélia M. N. dos Santos; Daisy M. Machado; Regina C. de M. Succi; Abes M. Amed; Reinaldo Salomão; Esper G. Kallás; M. Isabel de Moraes-Pinto
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 292 KB
- Volume
- 74B
- Category
- Article
- ISSN
- 1552-4949
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Despite the correlation between the use of protease inhibitors (PI) and adverse metabolic glycemic events, no prospective study has examined these parameters in pregnant women who use these drugs. ## Methods A prospective study was conducted on 57 pregnant women to inve
## Abstract Women account for almost 60% of human immunodeficiency virus type 1 (HIV‐1) infections in Sub‐Saharan Africa. HIV‐1 prevention tools such as condoms, abstinence and monogamy are not always feasible options for women due to various socio‐economic and cultural factors. Microbicides are an